Advertisement
U.S. Markets open in 2 hrs 59 mins

Calithera Biosciences, Inc. (CALA)

OTC Markets EXMKT - OTC Markets EXMKT Delayed Price. Currency in USD
Visitors trend2W10W9M
0.01000.0000 (0.00%)
At close: 03:00PM EST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
0
0
9,750
0
0
Operating Expense
53,062
42,074
74,308
91,387
92,895
Operating Income
-53,062
-42,074
-64,558
-91,387
-92,895
Net Non Operating Interest Income Expense
235
477
345
1,250
3,035
Other Income Expense
1,947
1,947
-50,875
-
-
Pretax Income
-101,924
-39,650
-115,088
-90,137
-89,860
Net Income Common Stockholders
-83,564
-21,290
-115,088
-90,137
-89,860
Average Dilution Earnings
-18,360
-18,360
0
0
-
Diluted NI Available to Com Stockholders
-101,924
-39,650
-115,088
-90,137
-89,860
Basic EPS
-4.60
-
-31.16
-26.20
-38.00
Diluted EPS
-7.94
-
-31.16
-26.20
-38.00
Basic Average Shares
4,633
-
3,693
3,441
2,366
Diluted Average Shares
4,992
-
3,693
3,441
2,366
Total Operating Income as Reported
-103,937
-42,074
-115,433
-91,387
-92,895
Total Expenses
53,062
42,074
74,308
91,387
92,895
Net Income from Continuing & Discontinued Operation
-101,924
-39,650
-115,088
-90,137
-89,860
Normalized Income
-52,827
-41,597
-64,213
-90,137
-89,860
Interest Income
477
477
345
1,250
3,035
Net Interest Income
235
477
345
1,250
3,035
EBIT
-53,062
-42,074
-64,558
-91,387
-92,895
EBITDA
-52,807
-41,819
-64,278
-91,023
-92,416
Reconciled Depreciation
255
255
280
364
479
Net Income from Continuing Operation Net Minority Interest
-101,924
-39,650
-115,088
-90,137
-89,860
Total Unusual Items Excluding Goodwill
-49,097
1,947
-50,875
0
0
Total Unusual Items
-49,097
1,947
-50,875
0
0
Normalized EBITDA
-3,710
-43,766
-13,403
-91,023
-92,416
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0